ERBB3 and BRAF Mutations as Potential Biomarkers in Non-Small Cell Lung Cancer Patients Under Immunotherapy-Based Treatments

被引：0
|
作者：
Robado de Lope, L. [1 ]
Serna-Blasco, R. [1 ]
Mediavilla, P. [1 ]
Sanz-Moreno, S. [1 ]
Rodriguez-Festa, A. [1 ]
Gallego-Gil, P. [2 ]
Flores, C. [1 ]
Calvo, V. [2 ]
Collazo-Lorduy, A. [2 ]
Blanco, M. [2 ]
Pena Cabia, S. [3 ]
Diz Tain, P. [4 ]
Garrido Onecha, M. L. [4 ]
Sanchez-Hernandez, A. [5 ]
Sequero Lopez, S. [6 ]
Rogado, J. [7 ]
Coves Sarto, J. [8 ]
Lopez Martin, A. [3 ]
Mielgo, X. [9 ]
Vazquez Estevez, S. [10 ]
Gonzalez-Rumayor, V. [11 ]
Romero, A. [2 ]
Provencio, M. [2 ]
机构：
[1] Inst Invest Sanitaria Puerta Hierro Segovia Arana, Majadahonda, Spain
[2] Hosp Univ Puerta Hierro Majadahonda, Majadahonda, Spain
[3] Hosp Univ Severo Ochoa, Leganes, Spain
[4] Complejo Asistencial Univ Leon, Leon, Spain
[5] Consorcio Hosp Prov Castellon, Castellon De La Plana, Spain
[6] Hosp Univ Clin San Cecilio, Granada, Spain
[7] Hosp Univ Infanta Leonor, Madrid, Spain
[8] Hosp Univ Son Llatzer, Palma de Mallorca, Spain
[9] Hosp Univ Fdn Alcorcon, Alcorcon, Spain
[10] Hosp Univ Lucus Augusti, Lugo, Spain
[11] Atrys Hlth, Barcelona, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Biomarkers; Immunotherapy; NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.22-16
引用
收藏
页码：S252 / S252
页数：1
相关论文
共 50 条
  • [41] Immunotherapy Benefit in a Patient With Non-Small Cell Lung Cancer and a Rare BRAF Mutation
    Rittberg, Rebekah
    Banerji, Shantanu
    Green, Susan
    Qing, Gefei
    Dawe, David E.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (10)
  • [42] Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy
    Garcia-Fernandez, Coral
    Fornaguera, Cristina
    Borros, Salvador
    CANCERS, 2020, 12 (06) : 1 - 26
  • [43] Understanding BRAF mutation in non-small cell lung cancer patients
    Tine, Mariaenrica
    Squarzoni, Giulia
    Ortolan, Davide
    Pezzuto, Federica
    Calabrese, Fiorella
    Squarzoni, Giulia
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [44] Expression of ErbB2 and ErbB3 in resected non- small cell lung cancer (NSCLC) patients (pts)
    Felip, E.
    Salcedo, M.
    Murtra-Garrell, N.
    Navarro, A.
    Teixido, C.
    Hernandez-Losa, J.
    Cedres, S.
    Martinez, P.
    Lopez, E.
    Montero, M. A.
    Freixinos, V.
    Argiles, G.
    Nunez, I.
    Peg, V.
    Pallisa, E.
    Canela, M.
    Tabernero, J.
    Ramon y Cajal, S.
    Tallada, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer
    Gerard, Catherine
    Debruyne, Channa
    MOLECULAR ONCOLOGY, 2009, 3 (5-6) : 409 - 424
  • [46] Analysis of correlations between driver mutations and biomarkers with response to immunotherapy in patients with metastatic non-small cell lung cancer (NSCLC).
    Yio, Jiang
    Wolf, Brian
    Yang, Amber
    Bayewitz, Ashrei Y.
    Xu, Yiqing
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients
    Bae, Nack Cheon
    Chae, Myung Hwa
    Lee, Myung Hoon
    Kim, Kyung Mee
    Lee, Eung Bae
    Kim, Chang Ho
    Park, Tae-In
    Han, Sung Beom
    Jheon, Sanghoon
    Jung, Tae Hoon
    Park, Jae Yong
    CANCER GENETICS AND CYTOGENETICS, 2007, 173 (02) : 107 - 113
  • [48] BRAF Mutations in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Chen, Dong
    Zhang, Li-Qun
    Huang, Jun-Fu
    Liu, Kai
    Chuai, Zheng-Ran
    Yang, Zhao
    Wang, Yun-Xia
    Shi, Da-Chuan
    Liu, Qian
    Huang, Qing
    Fu, Wei-Ling
    PLOS ONE, 2014, 9 (06):
  • [49] Biomarkers of response to immunotherapy in early stage non-small cell lung cancer
    Dugage, Matthieu Roulleaux
    Albarran-Artahona, Victor
    Laguna, Juan Carlos
    Chaput, Nathalie
    Vignot, Stephane
    Besse, Benjamin
    Mezquita, Laura
    Auclin, Edouard
    EUROPEAN JOURNAL OF CANCER, 2023, 184 : 179 - 196
  • [50] Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers
    Russano, Marco
    La Cava, Giulia
    Cortellini, Alessio
    Citarella, Fabrizio
    Galletti, Alessandro
    Di Fazio, Giuseppina Rita
    Santo, Valentina
    Brunetti, Leonardo
    Vendittelli, Alessia
    Fioroni, Iacopo
    Pantano, Francesco
    Tonini, Giuseppe
    Vincenzi, Bruno
    CURRENT ONCOLOGY, 2023, 30 (02) : 2366 - 2387
12345